Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | VNN1 | O95497 | 7/20 | 0.39 |
| ▸ | CPT2 | P23786 | 1/20 | 0.38 |
| ▸ | ACLY | P53396 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | PGD | P52209 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantoic Acid SCHEMBL29112230 | 1.00 | PTGS1 (0.48) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL7781736 | 1.00 | PTGS1 (0.48) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL213981 | 1.00 | PTGS1 (0.48) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL11576294 | 0.97 | PTGS1 (0.47) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL11576289 | 0.97 | PTGS1 (0.47) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL9630838 | 0.97 | PTGS1 (0.47) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL31205982 | 0.97 | PTGS1 (0.47) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL11575367 | 0.97 | PTGS1 (0.47) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL11575357 | 0.97 | PTGS1 (0.47) | PTGS1KCNH2VNN1CPT2ACLY | |
| Pantoic Acid SCHEMBL27567576 | 0.97 | PTGS1 (0.47) | PTGS1KCNH2VNN1CPT2ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2670 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056361-A | A nutrition-enhanced rhizoma Amorphophalli jelly and its preparation method | 雅客（中国）有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122036655-A | Recovery method of D-calcium pantothenate mother liquor | 江西天新药业股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-03 | — | — | US | claimed |
| US-20260022409-A1 | PANTOIC ACID-PRODUCING RECOMBINANT MICROORGANISM AND USE THEREOF | ANHUI HUAHENG BIOTECHNOLOGY CO LTD (CN) | 2026-01-22 | — | — | US | claimed |
| EP-4674950-A1 | RECOMBINANT MICROORGANISM FOR PRODUCING PANTOIC ACID AND USE THEREOF | Anhui Huaheng Biotechnology Co., Ltd. (CN) | 2026-01-07 | — | — | EP | claimed |
| US-12509706-B2 | Methods for preparing pantoic acid, pantothenic acid and panthenol as well as salts thereof | MINT BIOTECHNOLOGIES CO., LTD. (CN) | 2025-12-30 | — | — | US | claimed |
| US-20250369124-A1 | IMIDAZOLINE-SUGAR CONJUGATE COMPOSITIONS AND METHODS FOR INHIBITING CORROSION | ECOLAB USA INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-20250369123-A1 | ALKOXYIMIDAZOLINIUM QUATERNARY SALT COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS TO INHIBIT CORROSION | ECOLAB USA INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-20250290050-A1 | MICROORGANISM HAVING ENHANCED ACTIVITY OF 3-METHYL-2-OXOBUTANOATE HYDROXYMETHYLTRANSFERASE AND USES THEREOF | CJ CHEILJEDANG CORPORATION (KR) | 2025-09-18 | — | — | US | claimed |
| EP-4581096-A1 | COMPOSITIONS AND METHODS FOR DISSOLVING IRON SULFIDE AND INHIBITING CORROSION | ECOLAB USA INC. (US) | 2025-07-09 | — | — | EP | claimed |
| WO-1992018116-A1 | COMPOSITIONS COMPRISING 2-HYDROXYCARBOXYLIC ACIDS AND RELATED COMPOUNDS, AND METHODS FOR ALLEVIATING SIGNS OF DERMATOLOGICAL AGING | YU RUEY J (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0508324-A2 | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | Yu, Ruey J., Dr. (US) | 1992-10-14 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| US-4960696-A | Process for producing physiololgically active substance by multienzyme process | Imahori, Kazutomo (JP) | 1990-10-02 | — | — | US | claimed |
| EP-0273202-A2 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | Van Scott, Eugene J., Dr. (US) | 1988-07-06 | — | — | EP | claimed |
| US-4246261-A | HYDROXY ACIDS, ESTERS, LACTONES | SCOTT EUGENE J VAN | 1981-01-20 | — | — | US | claimed |
| US-4115443-A | Process of making D,L-lithium pantoate and resolving the racemic mixture into its optically active isomers | VEB JENAPHARM (DD) | 1978-09-19 | — | — | US | claimed |
| US-4111987-A | Lithium pantoate and optically active isomers thereof and process of making the same | V E B JENAPHARM (DD) | 1978-09-05 | — | — | US | claimed |
| US-3996246-A | Resolution of racemic pantolactone | BASF AKTIENGESELLSCHAFT (DT) | 1976-12-07 | — | — | US | claimed |